---
title: "TCT 2023: TRILUMINATE quality of life data point to benefit for patients with severe TR undergoing TEER"
date: "2023-10-26T18:59:10.000Z"
publishedDate: "26 octobre 2023"
summary: "Analysis of health status and quality of life data from the TRILUMINATE Pivotal trial, presented at TCT 2023 (23–26 October, San Francisco, USA) indicates that patients undergoing transcatheter edge-to-edge-repair (TEER) for severe tricuspid regurgitation provides “substantial” benefits for symptoms, functional status and quality of life compared to medical therapy, investigators have reported. Suzanne Arnold (Saint [&#8230;] The post TCT 2023: TRILUMINATE quality of life data point to benefit for patients with severe TR undergoing TEER appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/tct-2023-triluminate-quality-of-life-data-point-to-benefit-for-patients-with-severe-tr-undergoing-teer/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-10-26-tct-2023-triluminate-quality-of-life-data-point-to-benefit-for-patients-with-severe-tr-undergoing-teer"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/10/IMG_7964.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tct-2023-triluminate-quality-of-life-data-point-to-benefit-for-patients-with-severe-tr-undergoing-teer/"
---

![TCT 2023: TRILUMINATE quality of life data point to benefit for patients with severe TR undergoing TEER](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/10/IMG_7964.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tct-2023-triluminate-quality-of-life-data-point-to-benefit-for-patients-with-severe-tr-undergoing-teer/*

## L’essentiel

Analysis of health status and quality of life data from the TRILUMINATE Pivotal trial, presented at TCT 2023 (23–26 October, San Francisco, USA) indicates that patients undergoing transcatheter edge-to-edge-repair (TEER) for severe tricuspid regurgitation provides “substantial” benefits for symptoms, functional status and quality of life compared to medical therapy, investigators have reported. Suzanne Arnold (Saint [&#8230;] The post TCT 2023: TRILUMINATE quality of life data point to benefit for patients with severe TR undergoing TEER appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/tct-2023-triluminate-quality-of-life-data-point-to-benefit-for-patients-with-severe-tr-undergoing-teer/
